FFTY Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund ("ETF") that seeks to replicate the performance of the IBD 50 index, focusing on 50 US-listed stocks known for their aggressive growth characteristics. Launched on April 9, 2015, FFTY is issued by Innovator and employs a systematic approach to selecting holdings based on both fundamental and technical criteria.
FFTY's underlying index, the IBD 50, is renowned for identifying high-growth companies exhibiting strong earnings growth and price momentum. Innovator's ETF provides investors with exposure to a concentrated portfolio of stocks that are rigorously screened and selected for their potential to outperform broader market benchmarks.
Innovator's issuance of FFTY underscores its commitment to offering innovative investment solutions that cater to investors seeking exposure to dynamic growth opportunities in the US equity market. The ETF's strategy is designed to capitalize on the robust growth prospects of its constituent stocks while maintaining a disciplined approach to risk management and portfolio diversification.
Through FFTY, Innovator aims to provide investors with a transparent and efficient vehicle for accessing a select group of high-growth US equities. The fund's adherence to Innovator's principles of research-driven investment strategies and responsiveness to market trends reinforces its role as a preferred choice for investors looking to capitalize on growth-oriented investment themes.
|
